Oncology Nursing | Top Cancer Nursing Conferences| European Events | USA | 2017

Theme: Inspiring Innovations and Advanced Practice in Cancer Care

Cancer Nursing 2017

Cancer Nursing 2017 Scientific Program

Renowned Speakers

Maria Bohus
University Of Toronto
Canada

Madara Blumberga
Children University Hospital
Latvia

Florminda B Tejano
Holy Child Colleges of Butuan Hospital
Philippines

Sang Y Lee
The Pennsylvania State University College of Medicine
USA

Benedict Benigno
Ovarian Cancer Institute
USA

Jan Lewin
The University of Texas
USA

Niccola Funel
University of Pisa
Italy

Wassil Nowicky
Ukrainian Anti-Cancer Institute
Austria

Hiroshi Osawa
Edogawa Hospital
Japan

Kim Moretti
South Australian Prostate Cancer Clinical Outcomes Collaborative
Australia

Gino Fallone
University of Alberta
Canada

Juan F Roman
Project Reviewer Cambridge Consultants Medical Technology Division
UK

Julia Gerasimenko
Cardiff University
UK

Diana Anderson
University of Bradford
UK

Andreas Lehmann
Fraunhofer Institute for Ceramic Technologies and Systems IKTS
Germany

Tibor Tot
Central University Hospital
Sweden

Martin Burow
DMB-Diagnostics
Germany

Ajay Singh
University of South Alabama
USA

Pattie Cagney Sheehan
Second Act Cancer Recovery Boutique
USA

Seema Singh
University of South Alabama
USA

Jose-Luis Gomez-Ariza
University of Huelva
Spain

Martin Kristensson
Visiopharm
Denmark

Sanjay K. Srivastava
Texas Tech University USA
USA

Robert MC Williams
Mayo Clinic
USA

Christopher Doran
Central Queensland University
Australia

Karen M. Ong
Spot screen
Australia

Rossitza Lazova
Yale University
USA

Olivier E Pardo
Imperial College London
UK

Liane Deligdisch
Mount Sinai School of Medicine
USA

Xu Dong Zhang
University of Newcastle
Australia

Sabine Mai
University of Manitoba
Canada

Nicola Garbett
University of Louisville School of Medicine
USA

Thet Thet Lwin
Kitasato University
Japan

Alvaro Macieira-Coelho
French Institute of Health and Medical Research
France

Saad Kenderian
Mayo Clinic
USA

David J. Bearss
Tolero Pharmaceuticals
USA

Francesco Zinno
University of Rome Tor Vergata
Italy

Thomas Mehrling
Mundipharma EDO GmbH
Switzerland

Giuseppe Leone
Catholic University
Italy

Laura Griffin
Massachusetts General Hospital
USA

Hau C. Kwaan
Northwestern University
USA

Vincent Balaya
University Paris Desca
France

Saad M. Al-Shibli
International Islamic University
Malaysia

Mouad Edderkaou
Sinai Medical Center
USA

M.A. Nezami
Pacific Medical Center of Hope
USA

David K. Imagawa
University of California
USA

Mary McGowan
Chidlrens Cancer Centre
Australia

Jagat R Kanwar
Deakin University
Australia

Ines Vasconcelos
Berlin Oncological Center
Germany

Melissa Joyner
The University of Texas
USA

Stephen J. Beebe
Old Dominion University
USA

Stewart Sell
University of Albany
USA

Zhimin (James) Lu
The University of Texas
USA

Cancer Nursing 2017

ConferenceSeries Ltd welcomes you to attend the "25^th Cancer Nursing & Nurse Practitioners Conference” which is going to be held on July 17-18, 2017 at Lisbon, Portugal which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

The main theme of Cancer Nursing-2017 is "Inspiring Innovations and Advanced Practice in Cancer Care". Cancer Nursing 2017 is a global platform to discuss and learn about Cancer Prognosis, General Issues in Cancer Care, Cancer-Basic and Applied Research, Clinical Oncology & Tumor Specific Cancers, Advances in Cancer Therapy, Companion Diagnostics in oncology, Cancer Immunotherapy & Stem Cell Therapy, Cancer Treatment & Advancements in Cancer Therapies, Drug Discovery & Anti-Cancer Vaccines/drugs, Novel Approaches to Cancer Therapeutics and metabolomics, Breast Cancer & Treatment, Complementary and Alternative Medicine (CAM), Pediatric Oncology, Cancer Pain Management, Supportive Care Services & Lifestyle Connection, Gynecologic Oncology & Endocrine Oncology, Radiation Oncology.

ConferenceSeries Ltd Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members.

Why to attend???

With members from around the world focused on learning about Oncology and its advances; this is your best opportunity to reach the largest assemblage of participants from the Oncology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new ways of treatment & care, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Oncology are hallmarks of this conference.

A Unique Opportunity for Advertisers and Sponsors at this International event:

http://cancernursing.nursingconference.com/sponsors.php

Target Audience:

Scientists, Cancer Researchers, Cancer research Faculty, Medical Colleges, Cancer Associations and Societies, Chemotherapists, Physicians, Nursing Faculty, Business Entrepreneurs, Medical Devices, Manufacturing Companies, Pharmaceutical Companies, Oncologists, Radiologists, Pathologists, Academicians, Research Scholars, Students, Biomedical Companies, Diagnostics Companies.

Scope and Importance:

Nursing in cancer care focuses on patient assessment, education, symptom management, and supportive care. In medical oncology they play an integral role in the administration of antineoplastic agents and are responsible for safe drug handling; evaluation of laboratory data; calculation of drug dosages on the basis of body surface area; insertion of intravenous lines or accessing central venous devices; continuous and time intensive monitoring to address potential adverse reactions or drug interactions; and screening patients for inclusion in available research trials or protocols. In the radiation oncology arena the nurses need to have an understanding of radiobiology and radiation physics. They are also responsible for extensive symptom management, patient education and the submission process for clinical trials or research protocols.

ConferenceSeries Ltd welcomes you to attend the "25^th Cancer Nursing & Nurse Practitioners Conference" which is going to be held on July 17-18, 2017 at Lisbon, Portugal which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Cancer Nursing 2017 is a global platform to discuss and learn about Cancer Prognosis, General Issues in Cancer Care, Cancer-Basic and Applied Research, Clinical Oncology & Tumor Specific Cancers, Advances in Cancer Therapy, Companion Diagnostics in oncology, Cancer Immunotherapy & Stem Cell Therapy, Cancer Treatment & Advancements in Cancer Therapies, Drug Discovery & Anti-Cancer Vaccines/drugs, Novel Approaches to Cancer Therapeutics and metabolomics, Breast Cancer & Treatment, Complementary and Alternative Medicine (CAM), Pediatric Oncology, Cancer Pain Management, Supportive Care Services & Lifestyle Connection, Gynecologic Oncology & Endocrine Oncology, Radiation Oncology.

Track 1: General Issues in Cancer Nursing

Oncology nurses practice in a variety of environments which include acute care hospitals, private oncologists offices, ambulatory care clinics, radiation therapy facilities, home healthcare agencies, and community agencies. Health promotion describes of motivating people to welcome behaviors that both improve their emotional and physical quality of life and reduce the risk of premature morbidity and mortality. However most of the adults treated for cancer in the USA live free of disease for many years, several survivors experience long lasting side effects and complications of treatment. While others encounter recurrence or new cancers that require further treatment.

International Conference on Antimicrobial agents & Chemotherapy, October 19-20, 2017 Atlanta, Georgia USA; International Conference on GastroIntestinal Cancer and Therapeutics, October 16-18, 2017 Baltimore USA; International Conference on Urologic Oncology, June 26-28, 2017 Baltimore USA; International Conference on Blood Cancer & Treatment, June 26-27, 2017 London UK; IMPAKT 2017 Breast Cancer Conference, May 04-06, 2017 Brussels, Belgium; ELCC 2017 European Lung Cancer Conference, May 05-08, 2017 Geneva, Switzerland; International Conference on Innovative Approaches in Head & Neck Oncology, March 16-18, 2017 Barcelona Spain; Immune Regulation in Autoimmunity and Cancer, March 26-30, 2017 Columbia Canada.

Track 2: Clinical Cancer Nursing

Organ/Tumor Specific Cancers are the cancers named based on the location of cancer in the body organs. Cancer may affect about every organ in the human body. Each type of cancer is different with its own causes, symptoms and the methods of treatment. Lung cancer was considered to be the most common cancer worldwide in men causing nearly 17% of the total number of new cases which were diagnosed in the year 2012 and became a crucial topic for World Cancer Conferences. There are about 200 different types of cancers, but Breast cancer, Blood, lung, Head & Neck Cancer and leukemia cancers have been diagnosed with the highest frequency.

Track 3: Cancer Pain Management

The majority of people with cancer will experience pain at some time or another. The pain can result from the cancer itself, or from the cancer's treatment. In addition, some people who have been cured of their cancer can continue to suffer from pain. Cancer pain, or the discomfort that stems from cancer and its treatment, can be controlled most of the time, in which a nurse plays a important role. There are many different medicines and methods available to control cancer pain. People who have cancer and are feeling pain need to inform their doctor immediately. The earlier pain treatment is started, the more effective it will be.

Track 4: Cancer Immunotherapy & Stem Cell Therapy

This Session Includes Stem cell mediated immune gene therapy for tumors, Challenges and new opportunities with antibody drugs, Tumor-host interactions, nuclear responses and tumor genesis, Cancer biomarkers. The sectors covered are colony stimulating factors (CSFs), interferon Alfa and gamma products, interleukin products and therapeutic monoclonal antibodies, including antibody conjugates, cancer vaccines and other cancer treatment immunology products. Vaccines against HPV and hepatitis B are included; while such vaccines act only indirectly against cancer, they do serve to protect against the disease. Also covered is oncolytic virology, so new that its market tables have been presented separately from the immunotherapy tables.

Track 5: Cancer Prognosis

Prognosis is the outlook or the chance of recovery from cancer. New and better treatments are helping people diagnosed with breast cancer live longer than ever before. Cancer survival rates or survival statistics tell you the percentage of people who survive a certain type of cancer for a specific amount of time. Cancer statistics often use an overall five-year survival rate. An overall survival rate includes individuals of all ages and health conditions who have been diagnosed together with your cancer, together with those diagnosed terribly early and people diagnosed terribly late.

Track 6: Oncology Nursing Practice

Oncology has become one of the most important focus areas for pharmaceutical and biotech companies because of the high gear unmet need for improved handling for various types of Cancers. For an oncologist or an oncology nurse, to find the appropriate words to console a person who is suffering the loss of a loved one can be troublesome. This section discusses an oncologist's responsibility and perspective when it comes to subjects such as advanced cancer, hospice, do not resuscitate orders, cytotoxic therapy, maintaining a patient's dignity, supportive care and imminent decease.

Track 7: Complementary and Alternative Medicine (CAM)

Complementary and alternative medicine (CAM) is the term for medical products and practices that are not part of standard medical care. Some CAM therapies have undergone careful evaluation and have found to be safe and effective. However there are others that have been found to be ineffective or possibly harmful. CAM therapies need to be evaluated with the same long and careful research process used to evaluate standard treatments. Standard cancer treatments have generally been studied for safety and effectiveness through an intense scientific process that includes clinical trials with large numbers of patients.

Track 8: Supportive Care Services & Lifestyle Connection

A cancer diagnosis and its treatment can be overwhelming. Usually patients and family members have many questions and concerns about the disease and the treatment. The supportive care program helps patients and family members deal with the physical and emotional distress caused by the cancer diagnosis and treatment. The less distress patients have, the more energy they can direct toward recovery. Comprehensive supportive care services require the expertise of an interdisciplinary team in order to adequately assess and treat the complex needs of cancer patients and their families.

Track 9: Cancer Therapy and Treatment

The landscape of Cancer treatment has dramatically changed over the last four decades. The age when surgery and radiotherapy were the only effective way to fight tumor growth has ended. A complex scenario where the molecular features of tumors seem to be the cornerstone of any therapy is now emerging. Here we provide an overview on the different approaches to cancer treatment. Following, we focus on the understanding of the value of systemic treatment and on an up-date on the novel, up-coming therapies of the current targeted therapy age, including new antibodies, small molecules, anti-angiogenesis and viral therapy.

Track 10:Anti-Cancer Vaccines/drugs

Anti-cancer monoclonal antibodies can be targeted against malignant cells by several mechanisms. A cancer vaccine is a vaccine that either treats existing cancer or prevents development of a cancer. Vaccines that treat existing cancer are known as therapeutic cancer vaccines. There are currently no vaccines able to prevent all cancers. However, treatment often fails when cancer becomes resistant to anti-cancer drugs. Thus, drug resistance is a big challenge facing the survival of cancer patients.

Track 11: Cancer Prognosis

Prognosis is the outlook or the chance of recovery from cancer. New and better treatments are helping people diagnosed with breast cancer live longer than ever before. Cancer survival rates or survival statistics tell you the percentage of people who survive a certain type of cancer for a specific amount of time. Cancer survival rates are supported on research from information gathered on hundreds or thousands of individuals with a particular cancer. An overall survival rate includes individuals of all ages and health conditions who have been diagnosed together with your cancer, together with those diagnosed terribly early and people diagnosed terribly late.

Track 12: Cancer-Basic and Applied Research

Cancer Cell Biology, Diagnosis and Applied Research are using cell biological and other methods to investigate the mechanisms that regulate cell proliferation and differentiation. Cancer stem cells (CSCs) are cancer cells that possess characteristics associated with normal stem cells, the ability to give rise to all cell types found in a particular cancer sample. The process by which cancer cells spread to other parts of the body is also called metastasis. The metastasis of blood and lymphatic system cancers to the lung, central nervous system, heart and other tissues has been reported.

Track 13: Veterinary Oncology:

Veterinary oncology is a subspecialty of veterinary medicine that deals with cancer diagnosis and treatment in animals. Cancer is a major cause of death in pet animals. In one study, 45% of the dogs that reached 10 years of age or older died of cancer. Skin tumors are the most frequently diagnosed type of tumor in domestic animals for two reasons: 1. constant exposure of animal skin to the sun and external environment, 2. skin tumors are easy to see because they are on the outside of the animal. Companion animals such as dogs and cats suffer from many of the same types of cancer as humans.

ConferenceSeries Ltd is overwhelmed to announce the commencement of "25^th Cancer Nursing & Nurse Practitioners Conference" on July 17-18, 2017 in Lisbon, Portugal.

The upcoming conference will be organized around the theme "Caring is the Essence of Cancer Nursing".

Scope and Importance:

Why Lisbon, Portugal?

Lisbon is the capital and the largest city of Portugal, with a population of 552,700 within its administrative limits in an area of 100.05 km². Its urban area extends beyond the city’s administrative limits with a population of around 2.7 million people, being the 11th-most populous urban area in the European Union. About 2.8 million people live in the Lisbon Metropolitan Area (which represents approximately 27% of the country’s population).

Lisbon is recognized as a global city because of its importance in finance, commerce, media, entertainment, arts, international trade, education and tourism. It is one of the major economic centers on the continent, with a growing financial sector and one of the largest container ports on Europe's Atlantic coast. Lisbon Portela Airport serves over 20 million passengers annually, as of 2015, and the motorway network and the high-speed rail system of Alfa Pendular link the main cities of Portugal. The city is the 7th-most-visited city in Southern Europe. The city occupies 32nd place of highest gross earnings in the world. Most of the headquarters of multinationals in the country are located in the Lisbon area. It is also the political center of the country, as its seat of Government and residence of the Head of State.

The city is crossed by historical boulevards and monuments along the main thoroughfares, particularly in the upper districts; notable among these are the Avenue of Liberty, Avenida Fontes Pereira de Melo, Avenida Almirante Reis and Avenue of the Republic. The Pombaline Lower Town area covers about 235,620 square meters of central Lisbon. The Alfama is the oldest district of Lisbon, spreading on the slope between the Sao Jorge Castle and the Tejo River. The district contains many important historical attractions, as well as an abundance of Fado bars and restaurants. Bairro Alto is an area of central Lisbon that functions as a residential, shopping and entertainment district; it is the centre of the Portuguese capital's nightlife, attracting hipster youth and members of various music subcultures. Lisbon lacks the architecture and monuments of many other historic European capitals in large part due to the 1755 Lisbon earthquake, which destroyed most of Lisbon's buildings, including famous palaces and libraries, as well as most examples of Portugal's distinctive 16th-century Manueline architecture.

Conference Highlights:

Cancer Nursing

Cancer Cell Biology

Carcinogenesis and Mutagenesis

Cancer Biomarker

Cancer Nanotechnology

Cancer Pharmacology

Cancer Epidemiology

Nuclear Medicine

Cancer Trends and Opportunities

World Cancer Market

General Issues in Cancer Nursing

Cancer Therapy and Treatment

Complementary and Alternative Medicine

Cancer Pain Management

Supportive Care Services

Cancer Therapeutics and Metabolomics

Cancer Immunotherapy & Stem Cell Therapy

Cancer Basic and Applied Research

Companion Diagnostics in Oncology

Anti-Cancer Vaccines/Drugs

Breast Cancer Nursing

Surgical Oncology Nursing

Target Audience:

Scientists
Cancer Researchers
Cancer research Faculty
Medical Colleges
Cancer Associations and Societies
Chemotherapists
Physicians
Nursing Faculty
Business Entrepreneurs
Medical Devices Manufacturing Companies
Pharmaceutical Companies
Oncologists
Radiologists
Pathologists
Academicians
Research Scholars
Students
Biomedical Companies
Diagnostics Companies

Why to attend???

With members from around the world focused on learning about Oncology and its advances; this is your best opportunity to reach the largest assemblage of participants from the Oncology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new ways of treatment & care, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Oncology are hallmarks of this conference.

A Unique Opportunity for Advertisers and Sponsors at this International event:

http://cancernursing.nursingconference.com/sponsors.php

Market Analysis Report

Advances in understanding of the immune system are changing the way oncologists treat cancer. In recent years, researchers have increasingly looked to harnessing the patient's immune system in the management of difficult to treat cancers. While such an approach was once felt to be unattainable, a better understanding of how the adaptive immune system works has allowed the field of immuno-oncology to move to the clinic with increasing success. This study's objective was to assess practicing oncologists' familiarity with, and understanding of, immuno-oncology concepts that will play an important role in the care of patients with metastatic cancer such as those with lung cancer. A total of 469 of oncologist have participated in the surveys. Overall, oncologists reported a lack of familiarity and need for additional education in the areas of immunology as well as implications for immuno-oncology agents. Less than 15% of oncologists reported being very familiar with the immune system while 72% of learners indicated a need for additional education on adaptive immune responses. In addition, only 7% and11% of oncologists reported being very familiar with the concepts of immune escape and check points, respectively. Over 60% of oncologists reported little familiarity with emerging immunotherapies for the treatment of metastatic solid tumors, and a majority did not have a firm understanding of how to assess a patient's response According to the Asian healthcare industry is witnessing a paradigm shift, skewed towards point-of-care diagnostics, cost-effective personalized medicine, and treatment modalities, which not only offers efficient early diagnosis, but also treats cancer conditions in order to moderate the healthcare cost and disease liability. Cancer/Tumor profiling is one such technology with the exact potential to transform cancer/tumor diagnostics and therapeutics in the healthcare industry.

About 12.7 million cancer cases and 7.6 million cancer deaths are estimated to have occurred in 2008 worldwide, with 56% of the cases and 64% of the deaths in the economically developing world. Breast cancer, the most common tumor in women, presents a high survival percentage: 83% of patients have survived this type of cancer after five years. Lung cancer is one of the most aggressive tumors and survival after five years is very low: only 10% of patients diagnosed with a malignant neoplasm survive for more than five years. Colorectal cancer (of the colon and rectum), the most common malignant tumor if we group men and women together, presents an average survival rate of 50-55% five years after diagnosis, meaning that half the patients survive this form of cancer. Prostate cancer, today the most common tumor in men, has an increasingly favorable prognosis, with a global survival rate of 76%, which is higher in young adults. Ovarian cancer presents a very varied prognosis depending on age: whilst 70% of the group between 15 and 44 years survives this form of cancer, this is the case for only 19% of those over 74 years-old.

This market research report evaluates the Asian market of cancer/tumor profiling by geography, applications, technologies, and section types. Additionally, the requirements market is divided into five segments, namely Personalized Medicine, Biomarker Discovery, Diagnostics, Prognosis and Research Submissions; the technologies section is divided into five segments, namely Next-Generation Sequencing, Quantitative PCR, FISH/CISH, Immunohistochemistry, and Microarray; and finally, the segment types is partitioned into four parts, namely Genomics, Metabolomics, Proteomics, and Epigenetics. Of the above-mentioned application fragments, modified medicine is the largest revenue segment and NGS is the potential revenue yielding technology.

The cancer/tumor describing market was valued at $13.30 billion in 2012. At the end of 2013, the market is estimated to be $14.99 billion and is poised to reach around $35 billion by 2018, growing at a CAGR of 18.50% from 2013 to 2018.

The global market for cancer/tumor reporting is expected to grow, backed by technological advancements, investments, and huge funds. The market is endorsing a trend towards the development of personalized medicine and point-of-care diagnostic tests for cancer. Additionally, the demand for safe and cost-effective drugs for the treatment of cancer (which can be fulfilled by cancer/tumor profiling therapeutics), will fuel the market growth. However, the market will also experience improvements in biomarker discovery and prognosis areas during the forecast period.

Asia-Pacific is the largest hub for cancer/tumor profiling market, accounting for the largest share, followed by China and Australia. Asia-Pacific and Europe are expected to grow at a steady pace. However, the North America market and few countries from the ROW region are expected to witness a boost in demand and are poised to register maximum growth over the next five years, owing to high incidence of cancers, affected population, and the increased purchasing power of patients.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	July 17-18, 2017
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View

Media Partners

Association with

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

25th Cancer Nursing & Nurse Practitioners Conference July 17-18, 2017 Lisbon, Portugal

Recommended Global Nursing Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Renowned Speakers

Cancer Nursing 2017

Conference Highlights:

Why to attend???

A Unique Opportunity for Advertisers and Sponsors at this International event:

Conference Highlights

To Collaborate Scientific Professionals around the World

Media Partners

Association with

Association with

Association with

Useful Links

Special Issues